0001104659-23-046843.txt : 20230418
0001104659-23-046843.hdr.sgml : 20230418
20230418174938
ACCESSION NUMBER: 0001104659-23-046843
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230414
FILED AS OF DATE: 20230418
DATE AS OF CHANGE: 20230418
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GRAF FINCKENSTEIN FRIEDRICH
CENTRAL INDEX KEY: 0001782981
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36860
FILM NUMBER: 23827949
MAIL ADDRESS:
STREET 1: 999 SKYWAY ROAD
STREET 2: SUITE 150
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IOVANCE BIOTHERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001425205
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 753254381
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 825 INDUSTRIAL ROAD
STREET 2: 4TH FLOOR
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
BUSINESS PHONE: 6502607120
MAIL ADDRESS:
STREET 1: 825 INDUSTRIAL ROAD
STREET 2: 4TH FLOOR
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
FORMER COMPANY:
FORMER CONFORMED NAME: Lion Biotechnologies, Inc.
DATE OF NAME CHANGE: 20131015
FORMER COMPANY:
FORMER CONFORMED NAME: Genesis Biopharma, Inc
DATE OF NAME CHANGE: 20100319
FORMER COMPANY:
FORMER CONFORMED NAME: FREIGHT MANAGEMENT CORP
DATE OF NAME CHANGE: 20080128
4
1
tm2313085-2_4seq1.xml
OWNERSHIP DOCUMENT
X0407
4
2023-04-14
0
0001425205
IOVANCE BIOTHERAPEUTICS, INC.
IOVA
0001782981
GRAF FINCKENSTEIN FRIEDRICH
C/O IOVANCE BIOTHERAPEUTICS, INC.
825 INDUSTRIAL ROAD, 4TH FLOOR
SAN CARLOS
CA
94070
0
1
0
0
Chief Medical Officer
0
Common Stock
2023-04-14
4
M
0
2812
0
A
30930
D
Common Stock
2023-04-14
4
F
0
1395
5.64
D
29535
D
Restricted Stock Units
2023-04-14
4
M
0
2812
0.00
D
Common stock
2812
19690
D
2,812 of the restricted stock units ("RSUs") issued to the Reporting Person on January 14, 2022 vested and settled on April 14, 2023.
Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units. This is not an open market sale of securities.
Represents the common stock remaining after deducting the common stock withheld for taxes.
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
The remaining RSUs will vest in seven equal quarterly installments.
/s/ Friedrich Graf Finckenstein
2023-04-18